Table 2.

Adjusted^* Odds Ratios^† (95% confidence intervals) for prevalent baseline Elevated Hs-cTnT and Adjusted^* Beta-Coefficients^‡ for Expected Annual Change in Hs-cTnT, according to baseline categories of diastolic blood pressure (mmHg) (N=11,565)

	Cross-Sectional Analysis Elevated Hs-cTNT (≥14 ng/L)			Longitudinal Analysis Estimated Additional Annual Change (95% CI) in Hs-cTNT (ng/L)
Visit 2 Diastolic BP	n/N	Odds Ratio (95% CI)	p-value	Annual Change Between Visits 2 and 4	p-value	Annual Change Between Visits 4 and 5	p-value
<60 mm Hg	39/1087	2.24 (1.22, 4.10)	0.01	1.46 (0.51, 2.40)	0.002	−0.09 (−0.69, 0.51)	0.77
60–69 mm Hg	120/3728	1.52 (1.00, 2.32)	0.05	0.95 (0.28, 1.61)	0.005	0.32 (−0.69, 1.34)	0.54
70–79 mm Hg	144/4249	1.02 (0.71, 1.47)	0.90	0.85 (0.27, 1.44)	0.004	0.02 (−0.26, 0.31)	0.86
80–89 mm Hg	102/1902	1 (reference)	.	0 (reference)		0 (reference)
90–99 mm Hg	36/487	1.06 (0.61, 1.83)	0.84	−0.73 (−1.47, 0.01)	0.06	0.26 (−0.07, 0.60)	0.13
≥ 100 mm Hg	14/112	1.54 (0.63, 3.78)	0.34	−0.99 (−2.58, 0.58)	0.21	0.43 (−0.32, 1.18)	0.26

^*Adjusted for: age (years), race-center, gender, body mass index in kg/m², smoking (current; former; never), alcohol intake (current; former; never), systolic BP (in mmHg), hypertension medication use (yes, no), diagnosed diabetes (yes, no), LDL-cholesterol (mg/dL), HDL-cholesterol (mg/dL), triglycerides (mg/dL), current use of cholesterol-lowering medication (yes or no), and estimated glomerular filtration rate in mL/min/1.73m².

^†Logistic model for cross-sectional association between diastolic BP and baseline elevated hs-cTnT

^‡Linear model with generalized estimating equations and inverse probability of attrition weighting

Significant values in bold.

Hs-cTnT= high-sensitivity Troponin T, other abbreviations as per Table 1.